https://www.selleckchem.com/products/OSI-906.html
MALAT1 as a lncRNA may be a tumor suppressor in patients with CML. According to our data, MALAT1 may have potential role as a molecular biomarker for the occurrence and development of CML resistance to dasatinib. MALAT1 as a lncRNA may be a tumor suppressor in patients with CML. According to our data, MALAT1 may have potential role as a molecular biomarker for the occurrence and development of CML resistance to dasatinib. Radiofrequency ablation (RFA) is the current gold standard for palliative care of non-small cell lung cancer (NSCLC)
Like
Comment
Share
